Table 2.
Drug | Status | Properties |
---|---|---|
Infliximab | Approved for RA 1999(US) | Chimeric IgG1 anti-TNF-α antibody |
Etanercept | Approved 1998 (US) | Soluble TNF-receptor fusion protein |
Adalimumab | Approved 2002 (US) | Human monoclonal antibody to TNF |
Anakinra | Approved 2001 (US) | Recombinant IL-1 inhibitor |
Abatacept | Approved 2005 (US) | Costimulation blockers |
Rituximab | Approved for RA 2006 (US) | Chimeric anti-CD20 monoclonal antibody |
Tocilizumab | Filed for approval in Japan | Human antibody against IL-6 receptor |